Page 650 - Read Online

John et al. Hepatoma Res 2020;6:56 I http://dx.doi.org/10.20517/2394-5079.2020.37 Page 9 of 9

therapy for hepatic oligometastases. Pract Radiat Oncol 2016;6:86-95.
9. McPartlin A, Swaminath A, Wang R, Pintilie M, Brierley J, et al. Long-term outcomes of phase 1 and 2 studies of SBRT for hepatic
colorectal metastases. Int J Radiat Oncol Biol Phys 2017;99:388-95.
10. Joo JH, Park JH, Kim JC, Yu CS, Lim SB, et al. Local control outcomes using stereotactic body radiation therapy for liver metastases
from colorectal cancer. Int J Radiat Oncol Biol Phys 2017;99:876-83.
11. Mahadevan A, Blanck O, Lanciano R, Peddada A, Sundararaman S, et al. Stereotactic body radiotherapy (SBRT) for liver metastasis -
clinical outcomes from the international multi-institutional RSSearch(R) patient registry. Radiat Oncol 2018;13:26.
12. Ingold JA, Reed GB, Kaplan HS, Bagshaw MA. Radiation hepatitis. Am J Roentgenol Radium Ther Nucl Med 1965;93:200-8.
13. Hoyer M, Roed H, Traberg Hansen A, Ohlhuis L, Petersen J, et al. Phase II study on stereotactic body radiotherapy of colorectal
metastases. Acta Oncol 2006;45:823-30.
14. Decadt B, Siriwardena AK. Radiofrequency ablation of liver tumours: systematic review. Lancet Oncol 2004;5:550-60.
15. Stang A, Fischbach R, Teichmann W, Bokemeyer C, Braumann D. A systematic review on the clinical benefit and role of radiofrequency
ablation as treatment of colorectal liver metastases. Eur J Cancer 2009;45:1748-56.
16. Jackson WC, Tao Y, Mendiratta-Lala M, Bazzi L, Wahl DR. Comparison of stereotactic body radiation therapy and radiofrequency
ablation in the treatment of intrahepatic metastases. Int J Radiat Oncol Biol Phys 2018;100:950-8.
17. Dritschilo A, Grant EG, Harter KW, Holt RW, Rustgi SN, et al. Interstitial radiation therapy for hepatic metastases: sonographic guidance
for applicator placement. AJR Am J Roentgenol 1986;147:275-8.
18. Thomas DS, Nauta RJ, Rodgers JE, Popescu GF, Nguyen H, et al. Intraoperative high-dose rate interstitial irradiation of hepatic
metastases from colorectal carcinoma. Results of a phase I-II trial. Cancer 1993;71:1977-81.
19. Ricke J, Wust P, Wieners G, Beck A, Cho CH, et al. Liver malignancies: CT-guided interstitial brachytherapy in patients with unfavorable
lesions for thermal ablation. J Vasc Interv Radiol, 2004 15:1279-86.
20. Ricke J, Mohnike K, Pech M, Seidensticker M, Rühl R, et al. Local response and impact on survival after local ablation of liver
metastases from colorectal carcinoma by computed tomography-guided high-dose-rate brachytherapy. Int J Radiat Oncol Biol Phys
2010;78:479-85.
21. Mohnike K, Wolf S, Damm R, Seidensticker M, Seidensticker R, et al. Radioablation of liver malignancies with interstitial high-dose-rate
brachytherapy: complications and risk factors. Strahlenther Onkol 2016;192:288-96.
22. Tselis N, Chatzikonstantinou G, Kolotas C, Milickovic N, Baltas D, et al. Computed tomography-guided interstitial high dose rate
brachytherapy for centrally located liver tumours: a single institution study. Eur Radiol 2013 23:2264-70.
23. Collettini F, Singh A, Schnapauff D, Powerski MJ, Denecke T, et al. Computed-tomography-guided high-dose-rate brachytherapy (CT-
HDRBT) ablation of metastases adjacent to the liver hilum. Eur J Radiol 2013;82:e509-14.
24. Wieners G, Mohnike K, Peters N, Bischoff J, Kleine-Tebbe A, et al. Treatment of hepatic metastases of breast cancer with CT-guided
interstitial brachytherapy - a phase II-study. Radiother Oncol 2011;100:314-9.
25. Collettini F, Golenia M, Schnapauff D, Poellinger A, Denecke T, et al. Percutaneous computed tomography-guided high-dose-rate
brachytherapy ablation of breast cancer liver metastases: initial experience with 80 lesions. J Vasc Interv Radiol 2012;23:618-26.
26. Sharma DN, Thulkar S, Sharma S, Gandhi AK, Haresh KP, et al. High-dose-rate interstitial brachytherapy for liver metastases: first study
from India. J Contemp Brachytherapy 2013;5:70-5.
27. Kieszko D, Cisek P, Kordzińska-Cisek I, Grzybowska-Szatkowska L. Treatment of hepatic metastases with computed tomography-guided
interstitial brachytherapy. Oncol Lett 2018;15:8717-22.
28. Omari J, Heinze C, Damm R, Hass P, Janitzky A, et al. Radioablation of hepatic metastases from renal cell carcinoma with image-guided
interstitial brachytherapy. Anticancer Res 2019;39:2501-8.
29. Hass P, Mohnike K, Kropf S, Brunner TB, Walke M, et al. Comparative analysis between interstitial brachytherapy and stereotactic body
irradiation for local ablation in liver malignancies. Brachytherapy 2019;18:823-8.
30. Yeo SG, Kim DY, Kim TH, Kim SY, Hong YS, et al. Whole-liver radiotherapy for end-stage colorectal cancer patients with massive liver
metastases and advanced hepatic dysfunction. Radiat Oncol 2010;5:97.
31. Cunningham SC, Choti MA, Bellavance EC, Pawlik TM. Palliation of hepatic tumors. Surg Oncol 2007;16:277-91.
32. Greco C, Catalano G, Di Grazia A, Orecchia R. Radiotherapy of liver malignancies. From whole liver irradiation to stereotactic
hypofractionated radiotherapy. Tumori 2004;90:73-9.
33. Bydder S, Spry NA, Christie DR, Roos D, Burmeister BH, et al. A prospective trial of short-fractionation radiotherapy for the palliation
of liver metastases. Australas Radiol 2003;47:284-8.
34. Edyta WR, Jakub L, Jerzy W. Whole liver palliative radiotherapy for patients with massive liver metastases. Asian Pac J Cancer Prev
2015;16:6381-4.
35. Yin H, Lu K, Qiao WB, Zhang HY, Sun D, et al. Whole-liver radiotherapy concurrent with chemotherapy as a palliative treatment for
colorectal patients with massive and multiple liver metastases: a retrospective study. Asian Pac J Cancer Prev 2014;15:1597-602.
36. Torres-Roca JF. A molecular assay of tumor radiosensitivity: a roadmap towards biology-based personalized radiation therapy. Per Med
2012;9:547-57.